IS5294A - 4-Amínópýrról (3,2-d) pýrimidín sem mótlyf fyrir taugapeptíð Y viðtaka - Google Patents

4-Amínópýrról (3,2-d) pýrimidín sem mótlyf fyrir taugapeptíð Y viðtaka

Info

Publication number
IS5294A
IS5294A IS5294A IS5294A IS5294A IS 5294 A IS5294 A IS 5294A IS 5294 A IS5294 A IS 5294A IS 5294 A IS5294 A IS 5294A IS 5294 A IS5294 A IS 5294A
Authority
IS
Iceland
Prior art keywords
aminopyrrole
antagonist
pyrimidine
receptors
neuronal peptide
Prior art date
Application number
IS5294A
Other languages
English (en)
Inventor
Lee Dow Robert
Hammond Marlys
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS5294A publication Critical patent/IS5294A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS5294A 1997-08-05 1999-12-10 4-Amínópýrról (3,2-d) pýrimidín sem mótlyf fyrir taugapeptíð Y viðtaka IS5294A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5473497P 1997-08-05 1997-08-05
PCT/IB1998/001053 WO1999007703A1 (en) 1997-08-05 1998-07-10 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS

Publications (1)

Publication Number Publication Date
IS5294A true IS5294A (is) 1999-12-10

Family

ID=21993163

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5294A IS5294A (is) 1997-08-05 1999-12-10 4-Amínópýrról (3,2-d) pýrimidín sem mótlyf fyrir taugapeptíð Y viðtaka

Country Status (32)

Country Link
US (1) US6187778B1 (is)
EP (1) EP1003744B1 (is)
JP (1) JP3711238B2 (is)
KR (1) KR20010022583A (is)
CN (1) CN1264381A (is)
AP (1) AP9801312A0 (is)
AT (1) ATE296825T1 (is)
AU (1) AU7927498A (is)
BG (1) BG104107A (is)
BR (1) BR9811844A (is)
CA (1) CA2293621C (is)
CO (1) CO4960634A1 (is)
DE (1) DE69830409T2 (is)
EA (1) EA200000098A1 (is)
ES (1) ES2241146T3 (is)
GT (1) GT199800114A (is)
HR (1) HRP980434A2 (is)
HU (1) HUP0002956A3 (is)
ID (1) ID24300A (is)
IL (1) IL133430A0 (is)
IS (1) IS5294A (is)
MA (1) MA24629A1 (is)
NO (1) NO996178L (is)
OA (1) OA11277A (is)
PA (1) PA8456601A1 (is)
PE (1) PE106199A1 (is)
PL (1) PL338575A1 (is)
SA (1) SA98190435A (is)
TN (1) TNSN98148A1 (is)
TR (1) TR200000333T2 (is)
WO (1) WO1999007703A1 (is)
ZA (1) ZA986968B (is)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
IL148904A0 (en) * 1999-09-30 2002-09-12 Neurogen Corp Amino substituted pyrazolo {1,5,-a}-1,5- pyrimidines and pyrazolo{1,5,-a}-1,3,5-triazines
MXPA02006338A (es) * 1999-12-24 2002-12-13 Aventis Pharma Ltd Azaindoles.
GB0117396D0 (en) 2001-07-17 2001-09-05 Glaxo Group Ltd Chemical compounds
GB0308208D0 (en) 2003-04-09 2003-05-14 Glaxo Group Ltd Chemical compounds
MEP8409A (en) 2004-06-02 2011-12-20 Fused heterocyclic compound
EP1756093A1 (en) 2004-06-17 2007-02-28 Wyeth Processes for preparing gonadotropin releasing hormone receptor antagonists
AU2005264996A1 (en) 2004-06-17 2006-01-26 Wyeth Gonadotropin releasing hormone receptor antagonists
CA2575808A1 (en) * 2004-08-02 2006-02-16 Osi Pharmaceuticals, Inc. Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
MY179032A (en) 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
AU2006209117B2 (en) * 2005-01-28 2009-12-10 Daewoong Pharmaceutical Co., Ltd. Novel benzoimidazole derivatives and pharmaceutical composition comprising the same
KR20060087386A (ko) * 2005-01-28 2006-08-02 주식회사 대웅제약 신규 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물
US7538113B2 (en) 2005-02-18 2009-05-26 Wyeth 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7582634B2 (en) 2005-02-18 2009-09-01 Wyeth 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7534796B2 (en) 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US20090213731A1 (en) * 2005-04-15 2009-08-27 Regenertech Pty Limited Use of neuropeptide y (npy) and agonists and antagonists thereof for tissue regeneration
US7531542B2 (en) 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en) 2005-05-26 2009-09-01 Wyeth Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
CA2614544C (en) * 2005-07-13 2013-09-10 Banyu Pharmaceutical Co., Ltd. Heterocycle-substituted benzimidazole derivative
AR057525A1 (es) * 2005-10-03 2007-12-05 Astrazeneca Ab Compuestos inhibidores selectivos de gsk3 y un proceso para su preparacion
AR055669A1 (es) * 2005-10-03 2007-08-29 Astrazeneca Ab Derivados de 3h - imidazo[4, 5 -b]piridina como inhibidores selectivos de gsk3, metodos e internediarios para su preparacion, composiciones farmaceuticas que los contienen y su uso para la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y mentales.
US20070129364A1 (en) * 2005-12-07 2007-06-07 Han-Qing Dong Pyrrolopyridine kinase inhibiting compounds
WO2007072017A2 (en) * 2005-12-22 2007-06-28 The Institute Of Cancer Research Enzyme inhibitors
ES2374455T3 (es) 2006-02-17 2012-02-16 Pfizer Limited Derivados de 3-deazapurinza como moduladores de tlr7.
JP5606734B2 (ja) 2006-04-25 2014-10-15 アステックス、セラピューティックス、リミテッド 医薬化合物
KR101134239B1 (ko) 2006-07-11 2012-04-10 주식회사 대웅제약 신규한 바이아릴 벤조이미다졸 유도체 및 이를 함유하는 약학 조성물
PL2054405T3 (pl) * 2006-07-11 2014-03-31 Dae Woong Pharma Nowe pochodne biarylobenzimidazolu i zawierająca je kompozycja farmaceutyczna
CL2007002617A1 (es) 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
WO2008121064A1 (en) * 2007-03-30 2008-10-09 Astrazeneca Ab New imidazo[4,5-b]pyridine-6-halo-7-aryl/heteroaryl compounds 705
DE102007027800A1 (de) 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
ES2522365T3 (es) 2007-10-11 2014-11-14 Astrazeneca Ab Derivados de pirrolo [2,3-D] pirimidina como inhibidores de proteína quinasas B
CN101965350A (zh) 2008-01-11 2011-02-02 纳科法尔马有限公司 作为抗癌剂的新的吡唑并[3,4-d]嘧啶衍生物
PL2694056T3 (pl) 2011-04-01 2020-03-31 Astrazeneca Ab Leczenie terapeutyczne
PL2785349T5 (pl) 2011-11-30 2023-01-30 Astrazeneca Ab Kombinacja do leczenia nowotworu
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274213A (en) 1961-09-05 1966-09-20 Upjohn Co Alkoxy-substituted 2-phenyl-1-(tertiary-aminoalkoxy)phenyl-3, 4-dihydronaphthalenes
DE2818676A1 (de) * 1978-04-27 1979-11-08 Troponwerke Gmbh & Co Kg Substituierte 5,6-dimethylpyrrolo 2,3-d pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB9022644D0 (en) * 1990-10-18 1990-11-28 Ici Plc Heterocyclic compounds
US5877178A (en) * 1991-04-08 1999-03-02 Duquesne University Of The Holy Ghost Pyrimidine derivatives and methods of making and using these derivatives
US5235053A (en) * 1992-06-22 1993-08-10 Eli Lilly And Company Process for the synthesis of 4-hydroxy-5-halopyrrold[2,3-d]pyrimidine intermediates
US5284971A (en) 1992-07-16 1994-02-08 Syntex (U.S.A.) Inc. 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents
ES2108855T3 (es) 1992-07-21 1998-01-01 Ciba Geigy Ag Derivados de acido oxamico como agentes hipocolesteremicos.
EP0682027B1 (de) * 1994-05-03 1997-10-15 Novartis AG Pyrrolopyrimidinderivate mit antiproliferativer Wirkung
MX9702307A (es) * 1994-09-29 1998-04-30 Novartis Ag Pirrolo (2,3-d)pirimidinas y su uso.
US6562862B1 (en) 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
CA2203878C (en) 1994-11-07 2002-06-25 John M. Peterson Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
US5644057A (en) * 1995-05-12 1997-07-01 Neurogen Corporation Deazapurine derivatives; a new class of CRF1 specific ligands
EP0759441A3 (en) 1995-06-30 1999-06-30 Eli Lilly And Company Methods of treating neuropeptide Y-associated conditions
WO1997025041A1 (en) * 1996-01-09 1997-07-17 Eli Lilly And Company Benzimidzolyl neuropeptide y receptor antagonists

Also Published As

Publication number Publication date
ZA986968B (en) 2000-02-04
CO4960634A1 (es) 2000-09-25
CA2293621C (en) 2003-12-30
ID24300A (id) 2000-07-13
BR9811844A (pt) 2000-08-08
OA11277A (en) 2003-07-29
AP9801312A0 (en) 2000-01-30
ATE296825T1 (de) 2005-06-15
DE69830409D1 (de) 2005-07-07
CN1264381A (zh) 2000-08-23
SA98190435A (ar) 2005-12-03
WO1999007703A1 (en) 1999-02-18
MA24629A1 (fr) 1999-04-01
HUP0002956A2 (hu) 2001-08-28
NO996178L (no) 2000-02-14
HUP0002956A3 (en) 2002-01-28
JP3711238B2 (ja) 2005-11-02
US6187778B1 (en) 2001-02-13
PA8456601A1 (es) 2000-05-24
AU7927498A (en) 1999-03-01
TNSN98148A1 (fr) 2005-03-15
IL133430A0 (en) 2001-04-30
BG104107A (bg) 2000-08-31
PL338575A1 (en) 2000-11-06
ES2241146T3 (es) 2005-10-16
HRP980434A2 (en) 1999-04-30
KR20010022583A (ko) 2001-03-26
NO996178D0 (no) 1999-12-14
EP1003744B1 (en) 2005-06-01
JP2001512729A (ja) 2001-08-28
DE69830409T2 (de) 2006-01-26
TR200000333T2 (tr) 2000-05-22
EP1003744A1 (en) 2000-05-31
CA2293621A1 (en) 1999-02-18
PE106199A1 (es) 1999-11-02
GT199800114A (es) 2000-01-18
EA200000098A1 (ru) 2000-08-28

Similar Documents

Publication Publication Date Title
IS5294A (is) 4-Amínópýrról (3,2-d) pýrimidín sem mótlyf fyrir taugapeptíð Y viðtaka
ATE240936T1 (de) 1-amino-alkylcyclohexane als nmda-rezeptor- antagonisten
DE69812096D1 (de) Neuropeptid y rezeptorantagonisten
AU6144098A (en) Amide derivatives as selective neuropeptide y receptor antagonists
NO972016D0 (no) Indolyl-Y-reseptorantagonister
IS5706A (is) Adenosín A3 viðtakastillar
ID19623A (id) Antagonis reseptor vitronektin
ATE280157T1 (de) 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
AU5640199A (en) 4-quinolinemethanol derivatives as purine receptor antagonists (i)
ZA969485B (en) Excitatory amino acid receptor antagonists.
PT891978E (pt) Derivados de 5h-tiazolo (3,2-a) pirimidina
ID16742A (id) Antagonis reseptor endotelin
IS5410A (is) Ný mótlyf taugapeptíðs Y (NPY)
ID24726A (id) Antagonis-antagonis reseptor trombin
BR9611509A (pt) Antagonistas de receptores de aminoácidos excitativos
ID24162A (id) Antagonis-antagonis reseptor vitronektin
PT854867E (pt) Tetra-hidroquinolinas como antagonistas de nmda
ID28811A (id) Antagonis reseptor vitronektin
ID27845A (id) Turunan tetrahidrokuilina sebagai antagonis glisilina
AU2180600A (en) Non-peptide nk1 receptors antagonists
IL114932A0 (en) Excitatory amino acid receptor antagonists
ZA956812B (en) Excitatory amino acid receptor antagonists.
AU4980999A (en) A3 adenosine receptor antagonists
NO995033D0 (no) 6,7-disubstituerte-4-aminopyrido[2,3-D]pyrimidinforbindelser
NO995035D0 (no) 5,6,7-trisubstituerte-4-aminopyrido[2,3-D]pyrimidinforbindelser